Next Article in Journal
Heme Oxygenase 1 in the Nervous System: Does It Favor Neuronal Cell Survival or Induce Neurodegeneration?
Next Article in Special Issue
Copper(II) Bis(diethyldithiocarbamate) Induces the Expression of Syndecan-4, a Transmembrane Heparan Sulfate Proteoglycan, via p38 MAPK Activation in Vascular Endothelial Cells
Previous Article in Journal
Validation and Evaluation of Reference Genes for Quantitative Real-Time PCR in Macrobrachium Nipponense
Previous Article in Special Issue
Impact of Unsaturated Fatty Acids on Cytokine-Driven Endothelial Cell Dysfunction

A Novel Splice-Site Mutation in VEGFC Is Associated with Congenital Primary Lymphoedema of Gordon

Molecular and Clinical Sciences Institute, St George’s University of London, London SW17 0RE, UK
Institute of Cardiovascular Organogenesis and Regeneration, Faculty of Medicine, WWU Münster, 48149 Münster, Germany
CiM Cluster of Excellence (EXC1003 CiM), University of Münster, 48149 Münster, Germany
Northern Ireland Regional Genetics Service, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast BT9 7AB, UK
South West Thames Regional Genetics Unit, St George’s University Hospitals, London SW17 0RE, UK
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2018, 19(8), 2259;
Received: 5 July 2018 / Revised: 26 July 2018 / Accepted: 27 July 2018 / Published: 1 August 2018
(This article belongs to the Special Issue Vascular Endothelial Cells)
Lymphedema is characterized by chronic swelling of any body part caused by malfunctioning or obstruction in the lymphatic system. Primary lymphedema is often considered genetic in origin. VEGFC, which is a gene encoding the ligand for the vascular endothelial growth factor receptor 3 (VEGFR3/FLT4) and important for lymph vessel development during lymphangiogenesis, has been associated with a specific subtype of primary lymphedema. Through Sanger sequencing of a proband with bilateral congenital pedal edema resembling Milroy disease, we identified a novel mutation (NM_005429.2; c.361+5G>A) in VEGFC. The mutation induced skipping of exon 2 of VEGFC resulting in a frameshift and the introduction of a premature stop codon (p.Ala50ValfsTer18). The mutation leads to a loss of the entire VEGF-homology domain and the C-terminus. Expression of this Vegfc variant in the zebrafish floorplate showed that the splice-site variant significantly reduces the biological activity of the protein. Our findings confirm that the splice-site variant, c.361+5G>A, causes the primary lymphedema phenotype in the proband. We examine the mutations and clinical phenotypes of the previously reported cases to review the current knowledge in this area. View Full-Text
Keywords: primary lymphedema; Milroy; VEGFC; VEGFR3; FLT4 primary lymphedema; Milroy; VEGFC; VEGFR3; FLT4
Show Figures

Figure 1

MDPI and ACS Style

Nadarajah, N.; Schulte, D.; McConnell, V.; Martin-Almedina, S.; Karapouliou, C.; Mortimer, P.S.; Jeffery, S.; Schulte-Merker, S.; Gordon, K.; Mansour, S.; Ostergaard, P. A Novel Splice-Site Mutation in VEGFC Is Associated with Congenital Primary Lymphoedema of Gordon. Int. J. Mol. Sci. 2018, 19, 2259.

AMA Style

Nadarajah N, Schulte D, McConnell V, Martin-Almedina S, Karapouliou C, Mortimer PS, Jeffery S, Schulte-Merker S, Gordon K, Mansour S, Ostergaard P. A Novel Splice-Site Mutation in VEGFC Is Associated with Congenital Primary Lymphoedema of Gordon. International Journal of Molecular Sciences. 2018; 19(8):2259.

Chicago/Turabian Style

Nadarajah, Noeline, Dörte Schulte, Vivienne McConnell, Silvia Martin-Almedina, Christina Karapouliou, Peter S. Mortimer, Steve Jeffery, Stefan Schulte-Merker, Kristiana Gordon, Sahar Mansour, and Pia Ostergaard. 2018. "A Novel Splice-Site Mutation in VEGFC Is Associated with Congenital Primary Lymphoedema of Gordon" International Journal of Molecular Sciences 19, no. 8: 2259.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop